I've been writing a research report on BSX. Here's the current draft paragraph that I have on flexible endoscopes. Note that the 2006 date that appears below may be optimistic. I have to review what the company recently said about this. Off the top of my head, I believe that this may not happen until 2007.PhilFlexible endoscopes hold a number of advantages over more traditional rigid endoscopes: anesthesia is not required for most procedures, the patient does not need to assume any special positions, and there is greater flexibility during the examination process. It also uses a digital rather than an analog imaging system. In addition, currently marketed endoscopes are expensive, fragile and difficult to maintain, and provide a small field of vision. Plus, if the equipment is reused, a very detailed cleaning/sterilization process requiring a great deal of manual labor by trained personnel who must meet annual competency standards is needed in order to minimize the possibility of infection on reuse. BSX's single-use endoscopy technology would provide every patient with a new endoscope and may improve clinical outcomes. The technology would also reduce procedure time and increase procedural efficiency. It is hoped that BSX's flexible endoscope will be on the market in 2006. According to the company there are currently 15 million colonoscopies performed annually; this should grow to 21 million over time. Other potential markets, which include GI, urology, and gynecology, could mean a market of 40 million procedures. Based on an average selling price of $100 to $150 per procedure, this product could generate significant revenue ($1 billion or more)in the future.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra